Cammeby’s Capital Group

Represented Cammeby’s Capital Group, a New York -based venture capital fund, in its purchase of the Series A Preferred Stock of Melior Discovery, Inc., a developer of technology that uncovers new therapeutic indications for development stage pharmaceuticals.